Abstract
In a prospective 5-year study among Parkinson’s disease (PD) tremor-dominant (TD) patients, we investigated who will remain TD and who will later convert into the postural instability gait difficulty (PIGD) phenotype. At follow-up, 38% were still considered TD. At baseline the TD non-convertors had more years of education and better cognitive function than the convertors and significantly smaller deterioration in gait, balance, cognitive function and other non-motor symptoms. These results highlight the potential role of cognition in protecting against the development of PIGD symptoms.
References
Alves G, Larsen JP, Emre M, Wentzel-Larsen T, Aarsland D (2006) Changes in motor subtype and risk for incident dementia in Parkinson’s disease. Mov Disord 21:1123–1130
Arie L, Herman T, Shema-Shiratzky S, Giladi N, Hausdorff JM (2017) Do cognition and other non-motor symptoms decline similarly among patients with Parkinson’s disease motor subtypes? Findings from a 5-year prospective study. J Neurol 264:2149–2157
Burn DJ, Rowan EN, Allan LM, Molloy S, O’Brien JT, McKeith IG (2006) Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’s disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 77:585–589
Eisinger RS, Hess CW, Martinez-Ramirez D, Almeida L, Foote KD, Okun MS, Gunduz A (2017) Motor subtype changes in early Parkinson’s disease. Parkinsonism Relat Disord 43:66–72
Fereshtehnejad SM, Postuma RB (2017) Subtypes of Parkinson’s disease: what do they tell us about disease progression? Curr Neurol Neurosci Rep 17:34
Hariz GM, Forsgren L (2011) Activities of daily living and quality of life in persons with newly diagnosed Parkinson’s disease according to subtype of disease, and in comparison to healthy controls. Acta Neurol Scand 123:20–27
Jankovic J, Kapadia AS (2001) Functional decline in Parkinson disease. Arch Neurol 58:1611–1615
Kotagal V (2016) Is PIGD a legitimate motor subtype in Parkinson disease? Ann Clin Transl Neurol 3:473–477
Nutt JG (2016) Motor subtype in Parkinson’s disease: different disorders or different stages of disease? Mov Disord 31:957–961
Selikhova M, Kempster PA, Revesz T, Holton JL, Lees AJ (2013) Neuropathological findings in benign tremulous parkinsonism. Mov Disord 28:145–152
Stern Y (2002) What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 8:448–460
Acknowledgements
This work was supported in part by a Grant from the Michael J. Fox Foundation for Parkinson’s Research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
TH, LA, SS declare no financial or other conflicts of interest. Prof. Hausdorff reports Grants from Michael J Fox Foundation, during the conduct of the study. Prof. Giladi serves as a member of the Editorial Board for the Journal of Parkinson’s Disease. He serves as consultant to Teva- NeuroDerm, Biogen, Pharma2B, Denali, Abbvie, AccelMed, Monfort and UCB. He receives royalties from LTI and payment for lectures at Teva, UCB, Abviee, Bial and Movement Disorder Society. He received research support from the Michael J Fox Foundation, the National Parkinson Foundation, the European Union 7th Framework Program and the Israel Science Foundation as well as from Teva NNE program, Biogen, LTI, and Pfizer.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Herman, T., Shema-Shiratzky, S., Arie, L. et al. Who will remain tremor dominant? The possible role of cognitive reserve in the time course of two common Parkinson’s disease motor subtypes. J Neural Transm 125, 1007–1011 (2018). https://doi.org/10.1007/s00702-018-1859-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-018-1859-3